preeclampsia
Mirvie Raises $60M in Series B Funding
The company plans to use the funding to propel the clinical and commercial development of its Mirvie RNA testing platform for pregnancy health.
The South San Francisco-based startup recently published two studies showing the performance of its tests for predicting preterm birth and preeclampsia.
Paper-Based Test Being Developed to Improve Preeclampsia Diagnosis and for Decentralized Settings
Premium
The testing being developed at the University of Illinois at Chicago and Yale could make diagnosis of the condition more accessible in LMICs.
Renegade.bio, Metabolomic Diagnostics to Develop Preeclampsia Risk Screening Test for US Market
The firms will jointly develop a test that measures a panel of biomarkers in blood as early indicators of preeclampsia risk and creates a personalized risk profile.
Momm Diagnostics is currently benchmarking its offering against other tests for preeclampsia, while courting investors to support a new phase of development.